title: Differential effects of buffer pH on Ca(2+)-induced ROS emission with inhibited mitochondrial complexes I and III.
abstract: Excessive mitochondrial reactive oxygen species (ROS) emission is a critical component in the etiology of ischemic injury. Complex I and complex III of the electron transport chain are considered the primary sources of ROS emission during cardiac ischemia and reperfusion (IR) injury. Several factors modulate ischemic ROS emission, such as an increase in extra-matrix Ca(2+), a decrease in extra-matrix pH, and a change in substrate utilization. Here we examined the combined effects of these factors on ROS emission from respiratory complexes I and III under conditions of simulated IR injury. Guinea pig heart mitochondria were suspended in experimental buffer at a given pH and incubated with or without CaCl2. Mitochondria were then treated with either pyruvate, a complex I substrate, followed by rotenone, a complex I inhibitor, or succinate, a complex II substrate, followed by antimycin A, a complex III inhibitor. H2O2 release rate and matrix volume were compared with and without adding CaCl2 and at pH 7.15, 6.9, or 6.5 with pyruvate + rotenone or succinate + antimycin A to simulate conditions that may occur during in vivo cardiac IR injury. We found a large increase in H2O2 release with high [CaCl2] and pyruvate + rotenone at pH 6.9, but not at pHs 7.15 or 6.5. Large increases in H2O2 release rate also occurred at each pH with high [CaCl2] and succinate + antimycin A, with the highest levels observed at pH 7.15. The increases in H2O2 release were associated with significant mitochondrial swelling, and both H2O2 release and swelling were abolished by cyclosporine A, a desensitizer of the mitochondrial permeability transition pore (mPTP). These results indicate that ROS production by complex I and by complex III is differently affected by buffer pH and Ca(2+) loading with mPTP opening. The study suggests that changes in the levels of cytosolic Ca(2+) and pH during IR alter the relative amounts of ROS produced at mitochondrial respiratory complex I and complex III.
authors: Department of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA.
authors: Daniel P
authors: DP
authors: Lindsay
authors: Department of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA ; Cardiovascular Research Center, The Medical College of Wisconsin Milwaukee, WI, USA.
authors: Amadou K S
authors: AK
authors: Camara
authors: Department of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA ; Cardiovascular Research Center, The Medical College of Wisconsin Milwaukee, WI, USA ; Department of Physiology, The Medical College of Wisconsin Milwaukee, WI, USA ; Department of Anesthesiology, VA Medical Center Research Service Milwaukee, WI, USA ; Department of Biomedical Engineering, Marquette University Milwaukee, WI, USA.
authors: David F
authors: DF
authors: Stowe
authors: Department of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA.
authors: Ryan
authors: R
authors: Lubbe
authors: Department of Anesthesiology, The Medical College of Wisconsin Milwaukee, WI, USA.
authors: Mohammed
authors: M
authors: Aldakkak
keywords: Ca2+; mitochondrial complex I; mitochondrial complex III; mitochondrial permeability transition pore; pH; reactive oxygen species; simulated ischemia